This inventor holds 4 USPTO granted patents. Top assignees: Novozymes A/s, Novo Industri A/s. Active years: 1990-2007.
Company Filing History:
Years Active: 1990-2007
Title: Henrik Mollgaard: Innovator in Polypeptide Production
Introduction
Henrik Mollgaard is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of biotechnology, particularly in the production of polypeptides. With a total of 4 patents to his name, Mollgaard's work has advanced methods for cultivating mutant cells to enhance polypeptide production.
Latest Patents
Mollgaard's latest patents focus on innovative methods for producing polypeptides of interest. One of his inventions involves cultivating a mutant of a parent cell that includes a first nucleic acid sequence encoding the polypeptide and a second nucleic acid sequence that modifies genes responsible for toxin biosynthesis or secretion. This mutant produces less toxin than the parent cell under the same conditions, allowing for the isolation of the desired polypeptide from the culture medium. Additionally, he has developed methods for producing polypeptides in Aspergillus mutant cells, further showcasing his expertise in this area.
Career Highlights
Throughout his career, Mollgaard has worked with prominent companies such as Novozymes A/S and Novo Industri A/S. His experience in these organizations has contributed to his understanding and development of biotechnological innovations.
Collaborations
Mollgaard has collaborated with notable colleagues, including Bjorn Eggert Christensen and Svend Gunnar Kaasgaard. These partnerships have likely enriched his research and development efforts in the field.
Conclusion
Henrik Mollgaard's contributions to biotechnology, particularly in polypeptide production, highlight his innovative spirit and dedication to advancing scientific knowledge. His patents and collaborations reflect a commitment to improving methods in this vital area of research.